Articles tagged with Parkinsons Disease
Researchers have identified a crucial biological trigger of Huntington's disease, finding that methylation converts an important protein into waste. By targeting this process, they may develop effective therapies for other neurodegenerative diseases.
Researchers used PET scans to detect low cardiac norepinephrine levels in individuals with Parkinson's risk factors, finding that those with low radioactivity were highly likely to develop Parkinson's or Lewy body dementia. The study suggests a potential biomarker for early detection and treatment of these diseases.
Researchers at Texas A&M University have found a correlation between flavonoid compounds and reduced endometriosis symptoms. Flavonoids like Quercetin and Kaempferol show promise in easing inflammation, with studies suggesting they may help suppress the symptoms of inflammatory diseases like endometriosis.
Researchers found that changing treatment can lead to significant improvement in mobility and quality of life for patients with advanced Parkinson's disease. A nationwide registry is planned to develop scientifically sound guidelines for combination therapies.
A research team discovered that alpha-synuclein activates the plasma membrane calcium pump in negatively charged environments, preventing toxic cell buildup. This understanding has profound implications for unraveling early Parkinson's disease processes and potential diagnostic and therapeutic strategies.
A novel gene therapy strategy has been developed to specifically target and activate the direct pathway in Parkinson's disease-affected neurons, leading to improved motor symptoms such as bradykinesia and tremor. The approach has shown faster onset and longer duration compared to traditional L-Dopa treatment.
Researchers investigate centro-cingulate network changes and cholinergic innervation deficits in Parkinson disease and normal aging. Studies reveal significant correlations between centro-cingulate changes and cognitive impairments, motor symptoms, and age.
A recent study found that people living in areas with high levels of fine particulate matter have a 56% greater risk of developing Parkinson's disease. The Mississippi-Ohio River Valley and parts of Texas, Kansas, and eastern Michigan were identified as regions with higher rates of the disease.
Researchers describe traveling waves of acetylcholine in the striatum, revealing a new kind of neurochemical wave. The study proposes a mathematical mechanism by which simultaneous waves of acetylcholine and dopamine arise, maintaining balance in the brain's striatum.
Research suggests that Tai Chi practice can slow Parkinson's disease progression, improve non-motor symptoms, and lower medication needs over time. The study found significant benefits in disease severity, cognitive function, sleep quality, and complication prevalence in the Tai Chi group compared to the standard care group.
A team of researchers has created a 'proteomic clock' that can predict a healthy person's age based on their protein profile, revealing accelerated aging due to diseases. The study also detected proteins associated with Parkinson's disease in eye fluid, offering a potential pathway for earlier diagnoses.
Researchers at The Florey and Austin Health have discovered a way to detect Parkinson's disease 20-30 years before symptoms appear using a known biomarker called F-AV-133. PET scans show significant neuronal loss in three key brain regions, suggesting the biomarker is more sensitive than current methods.
A recent study by the University of Vienna and collaborators suggests that microbial metabolites may play a role in inducing Parkinson's-like symptoms. The researchers identified a specific bacterial metabolite that selectively damages dopamine-producing neurons, mirroring the neuronal loss observed in Parkinson's disease.
A study by researchers at the University of California - Riverside found that certain aspects of video game play can stimulate dopamine release and potentially aid in treating Parkinson's disease symptoms. The research suggests a promising new approach for managing the condition.
A new study by the National Neuroscience Institute suggests that drinking coffee and tea containing caffeine can significantly reduce the risk of Parkinson's disease in Asians who carry specific genetic variants. The study found that those who consumed higher amounts of caffeine had lower risks, even at moderate doses.
A large study of 491,000 participants found that loneliness was associated with an increased risk of developing Parkinson's disease. The findings suggest that loneliness is a significant psychosocial determinant of health and may contribute to the development of the neurodegenerative disorder.
A significant breakthrough sheds light on Parkinson's disease mechanisms, revealing that mitochondrial DNA damage triggers the spread of debilitating symptoms. The researchers' findings offer promising potential for innovative treatments and diagnostics.
A new study explores how alpha-synuclein disrupts metabolic processes in neurons. Researchers used NanoSIMS imaging techniques to visualize isotopic variations and found changes in carbon turnover, suggesting increased metabolic demands on affected cells.
A UNIGE team investigated the destruction of neurons at different times of the day using fruit fly models and found that cellular stress was more deleterious to neurons at night. This suggests that the circadian clock exerts a protective effect on dopaminergic neurons against oxidative stress.
In Parkinson's disease, the cerebral cortex compensates for lost dopamine cells by taking over tasks, which determines symptom severity. Exercise can stimulate this compensation and slow down disease progression.
Researchers have discovered a peptide that stabilizes the normal structure of alpha-synuclein protein, preventing misfolding and toxic clumps. This breakthrough could lead to new therapeutic developments for neurodegenerative diseases like Parkinson's.
Researchers identified potential therapeutic targets for Alzheimer's disease and other conditions using a new approach combining AI-driven target identification with protein phase separation analysis. The study provides insights into the role of protein phase separation in human disease and its potential as a therapeutic target.
Researchers at Lund University discovered a blood biomarker called DOPA decarboxylase (DCC) that can identify Parkinsonian diseases by measuring elevated levels in the blood, regardless of disease progression
Researchers at Aarhus University have unraveled the mystery of how lipid layers on cell surfaces accelerate Parkinson's disease misfolding. The study reveals that elevated concentrations cause alpha-synuclein to adopt an upright conformation, leading to easier refolding into dangerous aggregates.
A recent Cleveland Clinic trial found that augmented reality therapy, such as the Dual-task augmented Reality Treatment (DART), can improve posture and stability in individuals with Parkinson's disease. The digital platform uses a headset to guide exercises and track progress, allowing for more widespread use of physical therapy.
A new Northwestern Medicine study reveals that a dysfunction in the neuron's synapses leads to deficits in dopamine and precedes neurodegeneration in Parkinson's disease. The findings suggest targeting dysfunctional synapses before neurons degenerate may represent a better therapeutic strategy.
Prof. Dr. Thomas Gasser has been awarded the Breakthrough Prize in Life Sciences for discovering genetic risk factors for Parkinson's disease. He hopes his findings will lead to treatments targeting molecular causes and prevent or delay the onset of the disease.
Researchers developed a new imaging technique using Bessel beam two-photon microscopy to detect stalling in brain capillaries, which can indicate acute neurological issues. The approach generates clear images of all capillaries every two seconds, providing better temporal resolution and enabling the detection of short stalling events.
Doctors treating Parkinson's patients need to focus on the emotional and social impacts of stigma, in addition to motor symptoms. Stigma can lead to feelings of loneliness, depression, anxiety, and isolation, which significantly affect quality of life.
A study published in EMBO Molecular Medicine has identified the cellular processes that lead to Parkinson's disease in patients with CHCHD2 gene mutations. The research found that a specific protein, casein kinase 1 epsilon/delta (Csnk1e/d), plays a crucial role in the disease's pathogenesis.
A new AI tool assesses motor performance using finger taps, providing rapid and standardized ratings, comparable to expert neurologists. The test outperformed primary care physicians in accuracy, opening doors to evaluating other movement disorders.
Researchers at Tokyo Medical and Dental University found that mutant α-synuclein protein propagates through the brain's lymphatic system in its monomeric state before aggregating, shedding light on Parkinson's disease progression. The study suggests targeting early events may limit disease progression.
Researchers have developed a blood test that detects Parkinson's disease by quantifying DNA damage in mitochondrial cells. The test has been shown to identify patients with and without the genetic mutation LRRK2, potentially leading to early diagnosis and targeted therapies.
A study of medical and genetic data reveals that carrying a particular gene version reduces the risk of Alzheimer's and Parkinson's by over 10% on average. The protective allele, DR4, also correlates with a later onset of symptoms in both diseases.
Performing in a dance company strengthened the dancers' group identity, enabling them to negotiate their personal identity through embodied expression. This novel form of identity negotiation allowed the dancers to rediscover themselves and change their perception of the self.
Scientists at Van Andel Institute have discovered processes that enable the brain to adapt to damage in movement, cognition, and sensory perception circuits. This finding may help optimize current treatments or develop new ones that repair or bypass broken circuits.
Research suggests that certain gut problems, such as gastroparesis, dysphagia, and irritable bowel syndrome (IBS), may precede the development of Parkinson's disease. A nationwide medical record network study found a significant association between these conditions and an increased risk of Parkinson's diagnosis.
A recent NIH-supported study found a significant association between a genetic variant in people of African ancestry and an increased risk of developing Parkinson's disease. The variant, in the GBA1 gene, is associated with a higher risk of 3.5 times for those carrying two copies.
Researchers at Columbia University Irving Medical Center found that a misfolded protein triggers an immune attack in the gut, leading to gastrointestinal symptoms years before brain symptoms appear. The study suggests Parkinson's disease may be an autoimmune disorder and offers hope for early detection and prevention.
A study published in Neurology has identified markers of Parkinson's disease in eye scans, detecting the condition up to seven years before clinical presentation. Researchers used AI-powered analysis of retinal images from two large datasets to uncover subtle changes associated with Parkinson's.
Researchers at Lund University have successfully developed temporary, organic electrodes that can be seamlessly integrated into biological systems. This breakthrough enables the possibility of bioelectronics being implanted in and removed from the body without surgery.
Researchers found that rodents exposed to light for the first time in adulthood showed significant plasticity in their brains, challenging previous beliefs about adult brain rigidity. After a month, their brains looked similar to those of healthy controls, with organized visual responses and smaller receptive fields.
Chronic disease medications impair the body's ability to regulate core temperature, increasing the risk of heat-related illness in elderly patients. Exercise and improved fitness levels can help mitigate these effects, but bodily impairments from chemotherapy and medications may limit exercise capacity.
Researchers at Oregon Health & Science University have found that implanting a specific molecule in the brain can effectively reduce alcohol use among chronic heavy drinkers. The study showed a 90% reduction in drinking behavior in nonhuman primates, with the implanted virus permanently increasing dopamine levels and reducing cravings.
Research suggests football participation is associated with a higher odds of developing parkinsonism or Parkinson's disease. Longer football play duration and intensity are linked to an increased risk of diagnosis, highlighting the potential health risks for athletes involved in contact sports.
Patients with caregivers at higher depression risk experienced poorer quality of life and increased emergency department use. Additional caregiving resources could improve patient outcomes in Parkinson's disease.
Researchers found a significant link between playing tackle football and the risk of parkinsonism or PD diagnosis, even after accounting for known risk factors. Players who played at higher levels of competition experienced increased odds for having a reported diagnosis of PD.
Researchers used AI to accurately classify four subtypes of Parkinson's disease from patient-derived stem cells, with one subtype reaching an accuracy of 95%. The study suggests that personalized medicine and targeted drug discovery could be possible using this approach.
A study found that border-associated macrophages play a crucial role in neuroinflammation and neurodegeneration in Parkinson's disease. Deleting MHCII from these cells reduced neuroinflammation, suggesting they are essential for presenting alpha-synuclein antigens to T cells.
Research shows digital health platforms can deliver personalized nutrition services, decrease burden, and medical expenses. Facilitators include clear communication, training, and social interaction, while barriers include cognitive changes, technology difficulties, and privacy concerns.
Researchers from Shinshu University have developed a novel neuromodulation approach that incorporates gait-combined closed-loop transcranial electrical stimulation, demonstrating significant gait improvements in patients with Parkinson's disease. The treatment showed encouraging results after just ten repetitions, improving speed, gait...
Researchers have identified a diverse range of dopamine neurons that control movement, contradicting the long-held assumption that they only respond to rewards. The study sheds new light on Parkinson's disease, which affects motor skills despite the loss of dopamine neurons.
Researchers at Yale University reveal that the LRRK2 gene suppresses activity in lysosomes, microscopic organelles that break down cellular waste. This loss of function may explain the link between LRRK2 and Parkinson's disease, as well as other neurodegenerative conditions.
Mutations in parkin gene break down contacts between lysosomes and mitochondria, disrupting essential metabolite supply to mitochondria. Restoring these contacts may represent a new therapeutic opportunity for Parkinson’s disease.
Researchers have made key discoveries in a new stem cell-based therapy for Parkinson’s disease, using patients’ own cells to replace lost neurons. The approach, called an autologous therapy, has shown promise in reversing symptoms of the disease in rat models and holds potential for clinical trials with improved success rates.
Researchers at the University of Montreal found that movement circuits in mice brains are insensitive to dopamine levels, contradicting initial hypotheses. This discovery could lead to new approaches to reduce Parkinson's disease symptoms by identifying mechanisms involved in dopamine secretion.
Researchers at Lund University have developed a spinal fluid test to detect Lewy body disease before symptoms emerge. The study found that nearly ten percent of individuals without initial cognitive or motor difficulties had Lewy bodies in their brains, highlighting the potential for early detection and treatment.
Researchers have discovered a new mechanism underlying the neuroprotective effects of physical activity on Parkinson's disease. Intensive exercise has been shown to slow disease progression by restoring striatal synaptic plasticity and improving dopamine release, leading to better motor control and visuospatial learning.
Scientists found that cooling or warming the striatum region slows down or speeds up activity patterns, which correlates with rats' timing judgements. This provides evidence for the 'population clock hypothesis', suggesting that brains use decentralized and flexible sense of time.
Mass General Brigham researchers have made key improvements to Parkinson's disease cell therapies by using regulatory T cells to supplement neuronal cell therapy. The study shows that co-transplanting regulatory T cells with dopaminergic neurons increases survival and improves behavior recovery in rodent models.